Search Results - "Bohn, Pierre"

In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy.

Authors: Guisier, Florian Bohn, Pierre Patout, Maxime et al.

Source: PLoS ONE. 7/3/2017, Vol. 12 Issue 7, p1-12. 12p.

GMP-compliant automated synthesis and quality control of [¹⁷⁷Lu]Lu-PSMA-I&T using the GAIA/LUNA Elysia-Raytest module for the treatment of metastatic castration-resistant prostate cancer.

Authors: Coussirou, Amélie Six, Mélodie Edet-Sanson, Agathe et al.

Source: EJNMMI Radiopharmacy & Chemistry. 5/19/2026, Vol. 11 Issue 1, p1-17. 17p.

Immunotherapy by Immune Checkpoint Inhibitors and Nuclear Medicine Imaging: Current and Future Applications.

Authors: Decazes, Pierre Bohn, Pierre

Source: Cancers. Feb2020, Vol. 12 Issue 2, p371. 1p.

Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study

Authors: Vera, Pierre Bohn, Pierre Edet-Sanson, Agathe et al.

Source: Radiotherapy & Oncology. Jan2011, Vol. 98 Issue 1, p109-116. 8p.

Subjects: Cancer radiotherapy, Lung cancer treatment, Cancer tomography, Metabolism, Glucose, Hypoxemia, Analysis of variance, Statistical correlation, Thymidine

Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window.

Authors: Becker, Stéphanie Bohn, Pierre Bouyeure-Petit, Anne-Charlotte et al.

Source: Nuclear Medicine & Biology. Dec2015, Vol. 42 Issue 12, p923-930. 8p.

[¹²³I]-mIBG and [¹⁸F]-FDOPA differential uptake in the follow-up of neonatal neuroblastoma.

Authors: Edet-Sanson, Agathe Lechevallier, Marine Modzelewski, Romain et al.

Source: EJNMMI Reports. 10/6/2025, Vol. 9 Issue 1, p1-4. 4p.

^99mTc-(Me)FGCDEVD, a potential tracer for apoptosis detection

Authors: Bohn, Pierre Mouchard, Florian Rouvet, Jean et al.

Source: Bioorganic & Medicinal Chemistry Letters. Mar2013, Vol. 23 Issue 5, p1375-1378. 4p.

Design of silicon-based misonidazole analogues and ¹⁸F-radiolabelling

Authors: Bohn, Pierre Deyine, Abdallah Azzouz, Rabah et al.

Source: Nuclear Medicine & Biology. Nov2009, Vol. 36 Issue 8, p895-905. 11p.

New development of Meyers’ methodology: stereoselective preparation of an axially chiral 5,7-fused bicyclic lactam related to circumdatins/benzomalvins and asperlicins

Authors: Penhoat, Maël Bohn, Pierre Dupas, Georges et al.

Source: Tetrahedron: Asymmetry. Jan2006, Vol. 17 Issue 2, p281-286. 6p.

αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in ¹⁸F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study.

Authors: Aide, Nicolas Briand, Mélanie Bohn, Pierre et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2011, Vol. 38 Issue 2, p323-333. 11p.

Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.

Authors: Gouel, Pierrick Callonnec, Françoise Obongo-Anga, Franchel-Raïs et al.

Source: Cancers. Mar2023, Vol. 15 Issue 6, p1918. 15p.

The added value of clinical radiopharmacists in nuclear medicine: The example of glomerular filtration rate assessment in kidney donors.

Authors: Dinet, Juliette Becker, Stéphanie Le Cloirec, Joseph et al.

Source: Journal of Clinical Pharmacy & Therapeutics. Oct2020, Vol. 45 Issue 5, p1114-1119. 6p.

Radiotherapy boost in patients with hypoxic lesions identified by ¹⁸F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up].

Authors: Vera, Pierre Mihailescu, Sorina-Dana Lequesne, Justine et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2019, Vol. 46 Issue 7, p1448-1456. 9p. 1 Diagram, 2 Charts, 1 Graph.

Synthesis of Sulfonic Acid Derivatives by Oxidative Deprotection of Thiols Using tert-Butyl Hypochlorite.

Authors: Joyard, Yoann Papamicaël, Cyril Bohn, Pierre et al.

Source: Organic Letters. Vol. 15 Issue 9, p2294-2297. 4p.

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ¹⁸F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study).

Authors: Vera, Pierre Thureau, Sébastien Chaumet-Riffaud, Philippe et al.

Source: Journal of Nuclear Medicine. Jul2017, Vol. 58 Issue 7, p1045-1053. 9p. 1 Diagram, 4 Charts, 2 Graphs.

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.

Authors: Thureau, Sébastien Piton, Nicolas Gouel, Pierrick et al.

Source: Cancers. Aug2021, Vol. 13 Issue 16, p4101. 1p.

Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours.

Authors: Poret, Benjamin Desrues, Laurence Bonin, Marc-André et al.

Source: Biomolecules (2218-273X). Mar2020, Vol. 10 Issue 3, p471. 1p.

Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.

Authors: Peauger, Ludovic Azzouz, Rabah Gembus, Vincent et al.

Source: Journal of Medicinal Chemistry. Jul2017, Vol. 60 Issue 13, p5909-5926. 18p.

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.

Authors: Thureau, Sébastien Dubray, Bernard Modzelewski, Romain et al.

Source: Radiation Oncology. 10/23/2018, Vol. 13 Issue 1, pN.PAG-N.PAG. 1p.

ChemInform Abstract: Synthesis of Sulfonic Acid Derivatives by Oxidative Deprotection of Thiols Using tert-Butyl Hypochlorite.

Authors: Joyard, Yoann Papamicael, Cyril Bohn, Pierre et al.

Source: ChemInform. Sep2013, Vol. 44 Issue 37, pno-no. 1p.